
The first Biden-era vaccine against Covid-19 is moving toward market, but new bumps could trip up the big launch
CNN
The Biden administration is relishing the chance to put its new-and-improved distribution program on display with the release of the forthcoming Johnson & Johnson vaccine, but as the US Food and Drug Administration weighs authorization, expectations for a massive, imminent surge in available vaccine doses have been dashed. Federal health officials now expect to get fewer doses of the Johnson & Johnson vaccine in February and March, threatening their planned rollout.
Though the status of the Johnson & Johnson vaccine was brought up on the White House's weekly governors call Tuesday, several state officials and health providers tell CNN they're mostly in the dark about how the distribution will work. And due to a miscommunication over the production, CNN has learned the launch will be slower than federal health officials initially anticipated.
5 things to know for March 16: War with Iran, Oscar winners, Travel chaos, Severe weather, US airmen
CNN’s 5 Things AM brings you the news you need to know every morning.

The retirement of Illinois Sen. Dick Durbin after nearly 30 years in office sparked an expensive three-way Democratic primary that has showcased the party’s divisions over how to confront President Donald Trump’s immigration crackdown and introduced pro-crypto forces as an influence seeking to shape the midterm elections. The contest is also setting up a test of Gov. JB Pritzker’s political clout in the state as he eyes a potential 2028 presidential bid.











